Gates Package — page 61

Casco, Tony (NIH/NIAID) [C] From: Larry Zeitlin Sent: Wednesday, July 30, 2014 12:55 PM To: Trina Racine; deborah scott Ce: Frederick G *HS Hayden; Kobinger, Gary (Public Health Agency of Canada); Olinger, Gene (NIH/NIAID) [C]; Jahrling, Peter (NIH/NIAID) [E]; Mike Hensley; Hensley, Lisa (NIH/NIAID) [E]; Miles Brennan; Tara Nyhuis; Marshall Hoke Subject: Re: Combining the existing Phase 1 with a Therapeutic Portion Hi all, This is coming together very nicely. I'd like to suggest a follow-up call to discuss this in more detail and have cc'd our colleagues at CBR who have been leading the regulatory and clinical planning effort for ZMapp. Assuming everyone agrees a call would be worthwhile, can I trouble CBR to arrange it? Best, Larry From: Trina Racine RP oac-aspe.ge.ca> Date: Wednesday, July 30, 2014 at 8:43 AM To: deborah scott <MO sbcglobal.net> Cc: Frederick G *HS Hayden He hscmail.mce virginia.edu>, Gary Kobinger Olinger <I nih.gov>, Peter Jahrling {MMO niaid nih.gov>, MI Zeitlin <O mappbio.com>, Lisa Hensley <EN© nih.gov> Subject: Re: Combining the existing Phase 1 with a Therapeutic Portion Hello all, I too have made a number of comments and edits. Please let me know if you would like to discuss. Trina From: deborah scott @sboglobal.net> To: I Mike Hensley icloud.com>, Larry Zeitlin <EE@mapobio.com> Co: Frederick G *HS Hayden hscmail.mcc. virginia.edu>, "Peter \(NIH/NIAID\) \[E\I Jahrling" <{NMO niaid.nih.gov>, "Lisa \(NIH/NIAID\) \E\] Hensley" nih.gov>, I nih.gov \[Cl] Olinger" nih.gov>, "Gary Public Health Agency of Canada\) Kobinger" hav-aspc.gc.ca>, Tina Racine <BR vhac-aspc.gc.ca> Date: 2014-07-30 12:39 AM Subject! Re: Combining the existing Phase 1 with a Therapeutic Portion I've inserted comments and discussion points. please see attached Deb